Purchases and Sales Made in Q1 2023 in C4 Therapeutics, Inc. (CCCC)
This table provides information about the institutional ownership of C4 Therapeutics, Inc. (CCCC) during Q1 2023. The information is specifically focused on institutions that hold shares of C4 Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-85.1K- 22.43% |
$264K - $767K
|
294K
$1.25M
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-98.8K- 98.37% |
$306K - $892K
|
1.64K
$6.97K
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-108K- 39.81% |
$333K - $970K
|
163K
$691K
|
|
|
May 12, 2023
Q1 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-144K- 73.62% |
$445K - $1.3M
|
51.5K
$219K
|
|
|
May 15, 2023
Q1 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-728K- 98.5% |
$2.26M - $6.56M
|
11.1K
$47.1K
|
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.67M- 68.37% |
$5.19M - $15.1M
|
774K
$3.29M
|